Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion description "[We evaluated potential associations between clinical outcome and PVL presence in both methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) isolates from patients enrolled in two large, multinational phase three clinical trials assessing ceftaroline fosamil for the treatment of cSSSI (the CANVAS 1 and 2 programs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion evidence source_evidence_literature NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion SIO_000772 22623995 NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion wasDerivedFrom befree-20140225 NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_assertion wasGeneratedBy ECO_0000203 NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP388799.RAUNX5Wnt5OHytZ28F8aRJy9zAevRQ-UMGHBEa4OjaBAM130_provenance.